Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
MH Fermiano, AR das Neves, F Da Silva, MSA Barros… - Biomedicines, 2024 - mdpi.com
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
[HTML][HTML] Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
MH Fermiano, AR das Neves, F da Silva… - …, 2024 - ncbi.nlm.nih.gov
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
MH Fermiano, AR das Neves, F da Silva… - …, 2024 - search.proquest.com
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis.
MH Fermiano, AR das Neves, F da Silva… - Biomedicines, 2024 - europepmc.org
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
MH Fermiano, AR das Neves, F da Silva… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis.
MH Fermiano, AR das Neves, F da Silva, MSA Barros… - Biomedicines, 2024 - go.gale.com
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
[PDF][PDF] Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis. Biomedicines 2024, 12 …
MH Fermiano, AR das Neves, F da Silva, MSA Barros… - 2024 - researchgate.net
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
[PDF][PDF] Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis. Biomedicines 2024, 12 …
MH Fermiano, AR das Neves, F da Silva, MSA Barros… - 2024 - pdfs.semanticscholar.org
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In vitro Screening Against L. amazonensis
MH Fermiano, ARD Neves, F Da Silva, MSA Barros… - 2023 - preprints.org
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
Selenium-Containing (Hetero) Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis.
MH Fermiano, AR das Neves, F da Silva… - …, 2024 - search.ebscohost.com
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …